Indrayani Biotech share price gained over 2% on Wednesday, bouncing back from an over 4% fall in the previous session. Indrayani Biotech stock price has rallied over 10% in one week, but has fallen over 17% in three months and nearly 30% YTD. The penny stock has delivered multibagger returns over the long term, with a 851% jump in five years and 1,200% in seven years.
Open Flip
Reported Consolidated quarterly numbers for Max Healthcare Institute Limited are: Net Sales at Rs 1,707.46 crore in September 2024 up 25.26% from Rs. 1,363.16 crore in September 2023. Quarterly Net Profit at Rs. 281.81 crore in September 2024 up 1.85% from Rs. 276.68 crore in September 2023. EBITDA stands at Rs. 491.38 crore in September 2024 up 13.53% from Rs. 432.83 crore in September 2023.
Open Flip
Nifty 50 and Sensex held steady in the green, with investors betting on Donald Trump winning the US Presidential election, as a clear result would bring relief to the markets, positively impacting India's trade relations with the US. Nifty 50 was up 176.10 points or 0.73 percent at 24,389.40, and Sensex was up 587.64 points or 0.74 percent at 80,064.27.
Open Flip
